Table 2 Association of tumour side and clinicopathological parameters
From: Podocalyxin is a marker of poor prognosis in colorectal cancer
Location of the tumour | |||
|---|---|---|---|
Right hemicolon | Left hemicolon | ||
n (%) | 227 (27.0) | 613 (73.0) | p-value |
Age, years | |||
<65 | 89 (39.2) | 271 (44.2) | 0.209 |
≥65 | 138 (60.8) | 342 (55.8) | |
Gender | |||
Male | 119 (52.4) | 347 (56.6) | 0.310 |
Female | 108 (47.6) | 266 (43.4) | |
Dukes | |||
A | 21 (9.3) | 104 (17.0) | 0.129 |
B | 85 (37.4) | 209 (34.1) | |
C | 70 (30.8) | 161 (26.3) | |
D | 51 (22.5) | 139 (22.7) | |
Grade (WHO) | |||
1 | 7 (3.1) | 22 (3.6) | <0.0001 |
2 | 127 (56.7) | 444 (72.7) | |
3 | 74 (33.0) | 128 (20.9) | |
4 | 16 (7.1) | 17 (2.8) | |
Missing | 3 | 2 | |
HES9 | |||
Low | 189 (89.2) | 534 (96.2) | <0.001 |
High | 23 (10.8) | 21 (3.8) | |
Missing | 15 | 58 | |